Our Services
Medical Information
Helpful Resources
Published on: 6/15/2026
Methylene blue, a 19th-century compound, is gaining renewed attention as researchers explore its potential to support brain health. Early laboratory and clinical studies suggest it may enhance mitochondrial function, reduce oxidative stress, and inhibit tau protein aggregation—mechanisms linked to slowing or reversing cognitive decline. However, larger human trials are still needed to confirm these benefits.
Key considerations include dosing uncertainty, side effects such as serotonin syndrome and hemolytic anemia, and significant drug interactions. Anyone considering methylene blue should consult a healthcare provider first.
If you're experiencing memory issues, brain fog, or other cognitive symptoms, the most important first step is understanding what's actually causing them. Cognitive changes can stem from dozens of treatable conditions—not all require experimental therapies. Take a free, instant symptom check online to clarify what may be going on and identify the right next steps before exploring any treatment options.
Reviewed for medical accuracy: 06/15/2026
Methylene blue, first synthesized in the late 19th century, is experiencing renewed interest for its potential in slowing or reversing cognitive decline. Originally used as a dye and antimalarial agent, this compound has shown promise in laboratory and early clinical studies targeting neurodegenerative diseases such as Alzheimer's. Below, we explore the science behind methylene blue, summarize key research findings, highlight neurologists' cautions, and suggest practical next steps for anyone considering this treatment.
Researchers believe methylene blue can influence brain function through multiple mechanisms:
Mitochondrial Support
Reduction of Oxidative Stress
Inhibition of Tau Aggregation
Improved Cerebral Blood Flow
Though still in early stages, several studies have investigated methylene blue for memory and cognitive function:
Preclinical (Animal) Studies
Early Human Trials
Ongoing Research
Key Takeaway: While laboratory results are encouraging, definitive proof of clinical benefit in large human populations is still pending.
Leading neurologists emphasize a balanced view. Methylene blue is not a proven cure for dementia or Alzheimer's disease. Before considering its use, be aware of:
Dosage Uncertainty
Side Effects
Drug Interactions
Long-Term Safety
If you're intrigued by the potential of methylene blue for cognitive health, follow these guidelines:
Consult Your Physician
Monitor Closely
Lifestyle First
Stay Informed
Cognitive changes can stem from many causes—some reversible, others more serious. If you or a loved one notice any of the following, speak to a doctor right away:
For a convenient first step, you can use Ubie's free Medically approved LLM Symptom Checker Chat Bot to evaluate your cognitive symptoms and determine whether you should seek immediate medical attention.
Methylene blue is an intriguing "old" drug with potential to support mitochondrial function, reduce oxidative stress, and counter tau pathology in the brain. Early studies offer hope, but clear evidence of long-term cognitive benefits in large patient groups is still forthcoming. Neurologists urge caution around dosing, interactions, and side effects—especially serotonin syndrome and hemolytic anemia.
Before trying methylene blue:
If you have concerns about memory loss or other neurological symptoms, don't wait. Speak to a doctor and get personalized guidance by starting with Ubie's Medically approved LLM Symptom Checker Chat Bot to better understand your symptoms before your appointment.
Disclaimer: This information is intended for educational purposes and is not a substitute for professional medical advice. Always consult a qualified healthcare provider for personalized recommendations.
(References)
* Schirmer, M., von der Hagen, M., & Eickert, S. (2022). Methylene blue: A potential therapeutic option for neurodegenerative diseases. *Journal of Neurochemistry*, 161(2), 173-193. pubmed.ncbi.nlm.nih.gov/35165842/
* Gurevich, V. N., et al. (2024). Methylene blue: From mitochondrial medicine to neuroprotection, cognition, and beyond. *Mitochondrial Medicine (Basel)*, 1(1), 29-45. pubmed.ncbi.nlm.nih.gov/38317769/
* Wen, Y., et al. (2019). Methylene Blue in Alzheimer's Disease. *Journal of Alzheimer's Disease*, 70(s1), S197-S209. pubmed.ncbi.nlm.nih.gov/31034173/
* Gonzalez-Lima, F. (2018). Methylene Blue in Alzheimer's and other Neurodegenerative Diseases. *Current Neuropharmacology*, 16(7), 983-999. pubmed.ncbi.nlm.nih.gov/29322964/
* O'Leary, J. C., et al. (2016). Methylene blue in the treatment of neurodegenerative diseases: A review of current research. *Frontiers in Neuroscience*, 10, 524. pubmed.ncbi.nlm.nih.gov/27899880/
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.